Limits...
The effects of rivastigmine plus selegiline on brain acetylcholinesterase, (Na, K)-, Mg-ATPase activities, antioxidant status, and learning performance of aged rats.

Carageorgiou H, Sideris AC, Messari I, Liakou CI, Tsakiris S - Neuropsychiatr Dis Treat (2008)

Bottom Line: No statistically significant difference was observed in the cognitive performance.Both rivastigmine and selesiline alone improved performance, although they influenced the biochemical parameters in a different way.The combination of the two drugs did not affect learning performance.

View Article: PubMed Central - PubMed

Affiliation: Department of Pharmacology, Medical School, University of Athens Athens, Greece.

ABSTRACT

Unlabelled: We investigated the effects of rivastigmine (a cholinesterase inhibitor) and selegiline ((-)deprenyl, an irreversible inhibitor of monoamineoxidase-B), alone and in combination, on brain acetylcholinesterase (AChE), (Na(+), K(+))-, Mg(2+)-ATPase activities, total antioxidant status (TAS), and learning performance, after long-term drug administration in aged male rats. The possible relationship between the biochemical and behavioral parameters was evaluated.

Methods: Aged rats were treated (for 36 days) with rivastigmine (0.3 mg/kg rat/day ip), selegiline (0.25 mg/kg rat/day im), rivastigmine plus selegiline in the same doses and way of administration as separately. Aged and adult control groups received NaCl 0.9% 0.5 ml ip.

Results: TAS was lower in aged than in adult rats, rivastigmine alone does not affect TAS, decreases AChE activity, increases (Na(+), K(+))-ATPase and Mg(2+)-ATPase activity of aged rat brain and improves cognitive performance. Selegiline alone decreases free radical production and increases AChE activity and (Na(+), K(+))-ATPase activity, improving cognitive performance as well. In the combination: rivastigmine seems to cancel selegiline action on TAS and AChE activity, while it has additive effect on (Na(+), K(+))-ATPase activity. In the case of Mg(2+)-ATPase selegiline appears to attenuate rivastigmine activity. No statistically significant difference was observed in the cognitive performance.

Conclusion: Reduced TAS, AChE activity and learning performance was observed in old rats. Both rivastigmine and selesiline alone improved performance, although they influenced the biochemical parameters in a different way. The combination of the two drugs did not affect learning performance.

No MeSH data available.


Related in: MedlinePlus

Effects of rivastigmine, selegiline, and rivastigmine + selegiline on brain antioxidant status (TAS). TAS values were determined in each homogenized rat whole brain. Values of the groups of aged control rats and of rivastigmine indicate the mean ± standard error (SE) of ten independent experiments (ten rats). Values of the groups of adult control rats, of selegiline, and of rivastigmine + selegiline indicate the mean ± SE. of eleven independent experiments (eleven rats). The average value of each experiment arises from three determinations.Notes: NS, nonstatistical significance; ***P < 0.001 compared with aged control group; ###P < 0.001 compared with selegiline-treated group.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC2536534&req=5

fig1: Effects of rivastigmine, selegiline, and rivastigmine + selegiline on brain antioxidant status (TAS). TAS values were determined in each homogenized rat whole brain. Values of the groups of aged control rats and of rivastigmine indicate the mean ± standard error (SE) of ten independent experiments (ten rats). Values of the groups of adult control rats, of selegiline, and of rivastigmine + selegiline indicate the mean ± SE. of eleven independent experiments (eleven rats). The average value of each experiment arises from three determinations.Notes: NS, nonstatistical significance; ***P < 0.001 compared with aged control group; ###P < 0.001 compared with selegiline-treated group.

Mentions: Group (S) (received selegiline) showed a significant increase in TAS compared with the control group of aged rats (+30%, P < 0.001, tvalue = 9.66). Groups (R) (received rivastigmine) and (R + S) (received rivastigmine + selegiline) did not show any difference in comparison to the aged control group (tvalues = 0.48 and 1.13 respectively). TAS was significantly decreased in rivastigmine + selegiline-treated rats compared with selegiline-treated rats (-21%, P < 0.001, tvalue = 16.66) (Figure 1).


The effects of rivastigmine plus selegiline on brain acetylcholinesterase, (Na, K)-, Mg-ATPase activities, antioxidant status, and learning performance of aged rats.

Carageorgiou H, Sideris AC, Messari I, Liakou CI, Tsakiris S - Neuropsychiatr Dis Treat (2008)

Effects of rivastigmine, selegiline, and rivastigmine + selegiline on brain antioxidant status (TAS). TAS values were determined in each homogenized rat whole brain. Values of the groups of aged control rats and of rivastigmine indicate the mean ± standard error (SE) of ten independent experiments (ten rats). Values of the groups of adult control rats, of selegiline, and of rivastigmine + selegiline indicate the mean ± SE. of eleven independent experiments (eleven rats). The average value of each experiment arises from three determinations.Notes: NS, nonstatistical significance; ***P < 0.001 compared with aged control group; ###P < 0.001 compared with selegiline-treated group.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC2536534&req=5

fig1: Effects of rivastigmine, selegiline, and rivastigmine + selegiline on brain antioxidant status (TAS). TAS values were determined in each homogenized rat whole brain. Values of the groups of aged control rats and of rivastigmine indicate the mean ± standard error (SE) of ten independent experiments (ten rats). Values of the groups of adult control rats, of selegiline, and of rivastigmine + selegiline indicate the mean ± SE. of eleven independent experiments (eleven rats). The average value of each experiment arises from three determinations.Notes: NS, nonstatistical significance; ***P < 0.001 compared with aged control group; ###P < 0.001 compared with selegiline-treated group.
Mentions: Group (S) (received selegiline) showed a significant increase in TAS compared with the control group of aged rats (+30%, P < 0.001, tvalue = 9.66). Groups (R) (received rivastigmine) and (R + S) (received rivastigmine + selegiline) did not show any difference in comparison to the aged control group (tvalues = 0.48 and 1.13 respectively). TAS was significantly decreased in rivastigmine + selegiline-treated rats compared with selegiline-treated rats (-21%, P < 0.001, tvalue = 16.66) (Figure 1).

Bottom Line: No statistically significant difference was observed in the cognitive performance.Both rivastigmine and selesiline alone improved performance, although they influenced the biochemical parameters in a different way.The combination of the two drugs did not affect learning performance.

View Article: PubMed Central - PubMed

Affiliation: Department of Pharmacology, Medical School, University of Athens Athens, Greece.

ABSTRACT

Unlabelled: We investigated the effects of rivastigmine (a cholinesterase inhibitor) and selegiline ((-)deprenyl, an irreversible inhibitor of monoamineoxidase-B), alone and in combination, on brain acetylcholinesterase (AChE), (Na(+), K(+))-, Mg(2+)-ATPase activities, total antioxidant status (TAS), and learning performance, after long-term drug administration in aged male rats. The possible relationship between the biochemical and behavioral parameters was evaluated.

Methods: Aged rats were treated (for 36 days) with rivastigmine (0.3 mg/kg rat/day ip), selegiline (0.25 mg/kg rat/day im), rivastigmine plus selegiline in the same doses and way of administration as separately. Aged and adult control groups received NaCl 0.9% 0.5 ml ip.

Results: TAS was lower in aged than in adult rats, rivastigmine alone does not affect TAS, decreases AChE activity, increases (Na(+), K(+))-ATPase and Mg(2+)-ATPase activity of aged rat brain and improves cognitive performance. Selegiline alone decreases free radical production and increases AChE activity and (Na(+), K(+))-ATPase activity, improving cognitive performance as well. In the combination: rivastigmine seems to cancel selegiline action on TAS and AChE activity, while it has additive effect on (Na(+), K(+))-ATPase activity. In the case of Mg(2+)-ATPase selegiline appears to attenuate rivastigmine activity. No statistically significant difference was observed in the cognitive performance.

Conclusion: Reduced TAS, AChE activity and learning performance was observed in old rats. Both rivastigmine and selesiline alone improved performance, although they influenced the biochemical parameters in a different way. The combination of the two drugs did not affect learning performance.

No MeSH data available.


Related in: MedlinePlus